Patents by Inventor Rhys Whomsley

Rhys Whomsley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140073589
    Abstract: The present invention relates to amphetamine prodrugs which provide colonic release of amphetamine.
    Type: Application
    Filed: June 26, 2013
    Publication date: March 13, 2014
    Inventors: Rhys WHOMSLEY, Christine Elizabeth Allan, Timothy Jon Luker
  • Publication number: 20120178666
    Abstract: Prodrugs of guanfacine with amino acids or short peptides, pharmaceutical compositions containing such prodrugs and a method for providing therapeutic benefit in the treatment of ADHD/ODD (attention deficient hyperactivity disorder and oppositional defiance disorder) with guanfacine prodrugs are provided herein. Additionally, methods for minimizing or avoiding the adverse gastrointestinal side effects associated with guanfacine administration, as well as improving the pharmacokinetics of guanfacine are provided herein.
    Type: Application
    Filed: September 15, 2010
    Publication date: July 12, 2012
    Applicant: SHIRE LLC
    Inventors: Richard Franklin, Robert G. Tyson, Bernard T. Golding, Rhys Whomsley
  • Publication number: 20120065152
    Abstract: Prodrugs of guanfacine, pharmaceutical compositions containing such prodrugs and a method for providing therapeutic benefit in the treatment of ADHD/ODD (attention deficient hyperactivity disorder and oppositional defiance disorder) with guanfacine prodrugs are provided herein. Additionally, methods for improving the pharmacokinetics of guanfacine or minimizing or avoiding the adverse gastrointestinal side effects associated with guanfacine administration are provided herein.
    Type: Application
    Filed: September 14, 2011
    Publication date: March 15, 2012
    Applicant: SHIRE LLC
    Inventors: Rhys Whomsley, Bernard T. Golding, Robert G. Tyson
  • Publication number: 20110065796
    Abstract: Prodrugs of guanfacine with amino acids or short peptides, pharmaceutical compositions containing such prodrugs and a method for providing therapeutic benefit in the treatment of ADHD/ODD (attention deficient hyperactivity disorder and oppositional defiance disorder) with guanfacine prodrugs are provided herein. Additionally, methods for minimizing or avoiding the adverse gastrointestinal side effects associated with guanfacine administration, as well as improving the pharmacokinetics of guanfacine are provided herein.
    Type: Application
    Filed: September 15, 2010
    Publication date: March 17, 2011
    Applicant: SHIRE LLC
    Inventors: Rhys Whomsley, Richard Franklin, Bernard T. Golding, Robert G. Tyson